Evidence map›Paper›PMID 35323457›Full record

ArticleMarine drugs2022

Synthesis of Marine Cyclopeptide Galaxamide Analogues as Potential Anticancer Agents.

Daichun Li, Xiaojian Liao, Shenghui Zhong, Bingxin Zhao, Shihai Xu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Natural and Man-Made Cyclic Peptide-Based Antibiotics.Antibiotics (Basel, Switzerland) · 2022
    Review
  4. Cyclic Peptides for the Treatment of Cancers: A Review.Molecules (Basel, Switzerland) · 2022
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daichun LiDepartment of Chemistry, College of Chemistry and Materials Science, Jinan University, Guangzhou 510632, China.
Xiaojian LiaoDepartment of Chemistry, College of Chemistry and Materials Science, Jinan University, Guangzhou 510632, China.
Shenghui ZhongDepartment of Chemistry, College of Chemistry and Materials Science, Jinan University, Guangzhou 510632, China.
Bingxin ZhaoDepartment of Chemistry, College of Chemistry and Materials Science, Jinan University, Guangzhou 510632, China.
Shihai XuDepartment of Chemistry, College of Chemistry and Materials Science, Jinan University, Guangzhou 510632, China.

Funding

Department of Natural Resources of Guangdong Province GDNRC [2020] 037Department of Natural Resources of Guangdong Province GDNRC [2021] 48National Key Research and Development Plan of China 2018YFC0310900National Key Research and Development Plan of China 2019YFD0901905National Natural Science Foundation of China 41876145, 81874292, 21672084Science and Technology Planning Project of Guangzhou 202102010066, 201704030042
6 · The paper itself

Abstract

In this paper, eight new galaxamide analogues (

Indexed as

Antineoplastic AgentsApoptosisCell Line, TumorCell ProliferationDrug Screening Assays, AntitumorHumansHuman Umbilical Vein Endothelial CellsPeptides, CyclicAntineoplastic AgentsgalaxamidePeptides, Cyclicanticancerapoptosiscyclic pentapeptidedrug designgalaxamide analogues

Identifiers

PMID35323457
PMCPMC8949366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.